[Mirioron]

>So the big name brand drug companies just buys them all up. And because of that they no longer face competition from generics. They own both the name brands and the generics.

Didn't something like this happen with Martin Shkreli? From what I've read, the drug that they upped the price on had its patent expire decades ago. It's just that nobody else was producing the drug, presumably because it wouldn't make enough money. This resulted in essentially one company being the sole source of the drug, not because of patents, but because of cost.